Blueprint Medicines Research and Development Expenses 2014-2025 | BPMC
Blueprint Medicines research and development expenses for the twelve months ending March 31, 2025 were $0.345B, a 14.54% decline year-over-year.
- Blueprint Medicines annual research and development expenses for 2024 were $0.341B, a 20.17% decline from 2023.
- Blueprint Medicines annual research and development expenses for 2023 were $0.428B, a 10.41% decline from 2022.
- Blueprint Medicines annual research and development expenses for 2022 were $0.477B, a 20.57% decline from 2021.